CREBBP and Alzheimer disease: Fifth, the nuclear traslocation of the p300/CBP inhibitor EP300-interacting inhibitor of differentiation 1 (EID1) is increased in the brains of AD patients, and the overexpression of EID1 results in reduced levels of histone H3 and p53 acetylation, and βIII-tubulin downregulation [152].